2016- Steven M. Scott and Rebecca J. Scott Professorship Endowment
2015 Supplement Grant: Purchase of a Nano-LC System, Guo – P.I. NIH (1R01GM090270-06S)
Metabolic Engineering of Cancer for Selective Immunotargeting, Guo – P.I. NIH (2R01CA095142-11)
New Methods to Access GPI-Anchored Proteins and Study GPI-Anchored Proteomics, Guo – P.I. NIH (1R01GM090270-05)
Completed Research Projects
Paul Schaap Endowed Faculty Scholarship, Guo – P.I.
Synthesis and Applications of Fluorescent GPI Conjugates, Guo – P.I. NSF (CHE-1053848)
Novel Approaches to Access GPIs and GPI-Anchored Proteins for the Study of GPI Anchorage, Guo – P.I. NIH (1R01GM090270-01)
Metabolic Engineering of Cancer for Selective Immunotargeting, Guo – P.I. NIH (2R01CA095142-06)
MRI: Acquisition of an Analytical Field Emission Scanning Electron Microscope for Research and Teaching, Guo – co-P.I. (Coleman – P.I.) NSF (DMR-0922912)
Acquisition of a Cyber-Enabled 600 MHz NMR Spectrometer for Research and Teaching , Guo – co-P.I. (Coleman – P.I.) NSF (CHE-0840413)
Synthesis and Structure of GPIs and GPI-Linked Glycopeptides, Guo – P.I. NSF (CHE-0715275)
Development of DC-Based Cancer Vaccines, Guo – P.I. NSFC (China
Synthetic and Biological Studies of GPIs and Related Structures, Guo – P.I. Mizutani Foundation for Glycoscience (Japan)
Synthetic and Structural Studies of Sperm CD52, Guo – P.I. NSF (CHE-0407144)
Purchase of a 400 MHz NMR Spectrometer (instrument grant), Guo – co-P.I. (Sayre – P.I.) NSF (CHE-0320878)
Pathogen and Host Proteins in Pneumococcal Immunity , Guo – co-P.I. (Greenspan – P.I.) NIH (1R21AI53607-01)
Metabolic Engineering of Cancer for Selective Immunotargeting, Guo – P.I. NIH (1R01CA95142-01)
Cell-Selective Liposomal Drug Delivery in Restenosis, Guo – co-P.I. (Marchant – P.I.) NIH (1R01HL70263-01)
Free Carbohydrates as Phase-tags: Solution-phase Glycopeptide Synthesis with Solid-phase Workups, Guo – P.I. PRF of American Chemical Society
Novel Conjugate Vaccines for Encapsulated Bacterial Pathogens, Greenspan/Guo – P.I.s Presidential Research Initiative, CASE
Glycoengineering Cancer Cells for Selective Immunotargeting Cancer, Guo – P.I. Ohio Cancer Research Associates
A New Strategy for Glycopeptide Synthesis with Unprotected Oligosaccharide Chains as Phase Tags, Guo – P.I. Research Corporation (RI 0663)
Glycoengineering Melanoma Cells for Its Selective Immunotargeting, Guo – P.I. American Cancer Society